2020 Healthcare-Focused Sohn
New York | September 23, 2020
Over the course of 90 minutes, speakers delivered cutting edge and actionable healthcare investment insights, all in support of fighting COVID-19.
All proceeds of the September 23rd gathering support Rockefeller University’s Dr. Michel Nussenzweig, who is developing a novel therapy for COVID-19. Dr. Nussenzweig’s potent monoclonal antibodies against SARS-CoV-2 entered clinical trials in fall 2020. He is using an approach he pioneered several years ago discovering and harnessing neutralizing antibodies against HIV. Gilead Sciences recently acquired the license to develop this new HIV antibody therapy. The Nussenzweig lab continues to spearhead the design of effective therapies against other known and emerging global infectious diseases.
Founded in 1901, Rockefeller is the world’s leading biomedical research university, drawing top scientists and graduate students from around the world in pursuit of one mission: to conduct science for the benefit of humanity.
2020 Speakers
2020 Chairs
Thank You to Our Sponsors
CHAMPION
East Rock Capital
Will & Kacie Snellings
Anonymous
BENEFACTOR
Cormorant Asset Management
EcoR1 Capital
INNOVATOR
Boxer Capital
Josh Wolfe & Lauren Taylor Wolfe
CATALYST
Daniel Nir
Pointer Management
RBC Capital Markets
PIONEER
Cavalry Fund
Crescent Rock Capital Management
Crestone Capital, LLC
Gaute Ulltveit-Moe
Lineage Logistics
Anonymous
SohnX Australia
November 13, 2020
In 2020, Sohn Australia adapted its conference format and for the first time was held virtually. The SohnX Australia Instigator Virtual Conference featured fund manager stock pitches and macro fireside conversations with international thought leaders.
2020 Speakers
SohnX Hong Kong
September 9, 2020
The Karen Leung Foundation is proud to have presented the 8th Annual Sohn Hong Kong Virtual Investment Leaders Conference as a part of the virtual SohnX initiative. As with every year, the conference brought together Asia’s leading investors to support the fight against gynecological and pediatric cancers by promoting research, education, prevention and optimal treatment. To address travel and social gathering restrictions, the main sessions of the event were accessible virtually via live stream.
The Conference was a must-attend event as it provided a forum for successful professional investors to present a market view or investment idea, allowing attendees to gain valuable insights from leaders in the field. Programming included live Next Wave and Main Stage presentations, interactive elements such as Q&A and polling, networking and virtual information booths.
2020 Speakers
SohnX San Francisco
October 6, 2020
In 2020, we brought the Bay Area’s premier investor event online, with insights and expertise from some of the top portfolio managers in the business. This year’s virtual conference featured best ideas from some of the West Coast’s top investors, plus a fireside chat with Howard Marks.
Since inception, the Sohn San Francisco Investment Conference, organized by the Excellence in Investing for Children’s Causes Foundation, has raised over $1.7 million dollars to support Bay Area organizations focused on improving educational opportunities and life outcomes for underserved youth.
For more information on the 2020 SohnX San Francisco Investment conference or information about sponsorships, please contact the Sohn San Francisco team: adam@strausevents.com.
2020 Speakers